Peptomyc Company
Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.
Investors
Technology:
Data-driven Technologies
Industry:
Clinical development, PharmTech
Headquarters:
Barcelona, Catalonia, Spain
Founded Date:
2014-12-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
10
Total Funding:
22792000
Estimated Revenue:
Less than $1M
Last Funding Date:
2022-01-18
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership